Jacob Fredsøe

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 12

Top Venues

NPJ precision oncology

British journal of cancer

Acta oncologica (Stockholm, Sweden)

Diagnostics (Basel, Switzerland)

Aarhus University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Aarhus University Aug 01 2014

Denmark

Assistant Professor :: Molecular Medicine

Publications

Martin Rasmussen, Jacob Fredsøe, Paul Vinu Salachan, Marcus Pii Lunau Blanke, Stine Hesselby Larsen, Benedicte Parm Ulhøi, Jørgen Bjerggaard Jensen, Michael Borre, Karina Dalsgaard Sørensen
Stroma-specific gene expression signature identifies prostate cancer subtype with high recurrence risk. NPJ precision oncology 8 (1) (2024)
Martin Rasmussen, Jacob Fredsøe, Paul Vinu Salachan, Marcus Pii Lunau Blanke, Stine Hesselby Larsen, Benedicte Parm Ulhøi, Jørgen Bjerggaard Jensen, Michael Borre, Karina Dalsgaard Sørensen
Stroma-specific gene expression signature identifies prostate cancer subtype with high recurrence risk. NPJ precision oncology 8 (1) (2024)
Martin Rasmussen, Jacob Fredsøe, Paul Vinu Salachan, Marcus Pii Lunau Blanke, Stine Hesselby Larsen, Benedicte Parm Ulhøi, Jørgen Bjerggaard Jensen, Michael Borre, Karina Dalsgaard Sørensen
Stroma-specific gene expression signature identifies prostate cancer subtype with high recurrence risk. NPJ precision oncology 8 (1) (2024)
Jacob Fredsøe, Eske Glud, Lars Boesen, Vibeke Løgager, Mads Hvid Poulsen, Bodil Ginnerup Pedersen, Michael Borre, Karina Dalsgaard Sørensen
Danish Prostate Cancer Consortium Study 1 (DPCC-1) protocol: Multicentre prospective validation of the urine-based three-microRNA biomarker model uCaP. BMJ open 13 (11) (2023)
Søren Klingenberg, Jacob Fredsøe, Karina Dalsgaard Sørensen, Benedicte P Ulhøi, Michael Borre, Mads R Jochumsen, Kirsten Bouchelouche
Recurrence rate after radical prostatectomy following primary staging of high-risk prostate cancer with 68 Ga-PSMA PET/CT. Acta oncologica (Stockholm, Sweden) 61 (10) (2022)
Martin Rasmussen, Jacob Fredsøe, Amy L Tin, Andrew J Vickers, Benedicte Ulhøi, Michael Borre, James Eastham, Behfar Ehdaie, Bertrand Guillonneau, Vincent Laudone, Peter T Scardino, Karim Touijer, Karina Dalsgaard Sørensen, Hans G Lilja
Independent validation of a pre-specified four-kallikrein marker model for prediction of adverse pathology and biochemical recurrence. British journal of cancer 126 (7) (2021)
Jacob Fredsøe, Jan Koetsenruijter, Peter Vedsted, Pia Kirkegaard, Michael Væth, Adrian Edwards, Torben F Ørntoft, Karina Dalsgaard Sørensen, Flemming Bro
The effect of assessing genetic risk of prostate cancer on the use of PSA tests in primary care: A cluster randomized controlled trial. PLoS medicine 17 (2) (2020)
Jacob Fredsøe, Pia Kirkegaard, Adrian Edwards, Peter Vedsted, Karina Dalsgaard Sørensen, Flemming Bro
A genetic risk assessment for prostate cancer influences patients' risk perception and use of repeat PSA testing: a cross-sectional study in Danish general practice. BJGP open 4 (2) (2020)
Marianne Trier Bjerre, Maibritt Nørgaard, Ole Halfdan Larsen, Sarah Østrup Jensen, Siri H Strand, Peter Busch Østergren, Mikkel Fode, Jacob Fredsøe, Benedicte Parm Ulhøi, Martin Mørck Mortensen, Jørgen Bjerggaard Jensen, Michael Borre, Karina Dalsgaard Sørensen
Epigenetic Analysis of Circulating Tumor DNA in Localized and Metastatic Prostate Cancer: Evaluation of Clinical Biomarker Potential. Cells 9 (6) (2020)
Jacob Fredsøe, Anne K I Rasmussen, Peter Mouritzen, Marianne T Bjerre, Peter Busch Østergren, Mikkel Fode, Michael Borre, Karina Dalsgaard Sørensen
Profiling of Circulating microRNAs in Prostate Cancer Reveals Diagnostic Biomarker Potential. Diagnostics (Basel, Switzerland) 10 (4) (2020)
Jacob Fredsøe, Anne K I Rasmussen, Peter Mouritzen, Michael Borre, Torben Ørntoft, Karina Dalsgaard Sørensen
A five-microRNA model (pCaP) for predicting prostate cancer aggressiveness using cell-free urine. International journal of cancer 145 (9) (2019)
Marianne T Bjerre, Siri H Strand, Maibritt Nørgaard, Helle Kristensen, Anne Ki Rasmussen, Martin Mørck Mortensen, Jacob Fredsøe, Peter Mouritzen, Benedicte Ulhøi, Torben Ørntoft, Michael Borre, Karina Dalsgaard Sørensen
Aberrant DOCK2, GRASP, HIF3A and PKFP Hypermethylation has Potential as a Prognostic Biomarker for Prostate Cancer. International journal of molecular sciences 20 (5) (2019)

Jacob Fredsøe.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jacob Fredsøe